$CCLD

CareCloud (CCLD) reported record Q3 2026 earnings with revenue of $33.7M (+9% YoY), GAAP net income of $4.7M (+54% YoY), and EPS of $0.10. The company attributed growth to AI automation, expense discipline, and revenue mix shifts. It also completed a capital structure transformation, reducing preferred dividends by 86% and repaying debt. CareCloud highlighted growth engines like enterprise AI and compliance services, reaffirming its full-year outlook.

Healthcare stocks rallied after corporate updates. LABT surged 240% after redeeming preferred shares, ADMA rose 29% with Q3 revenue of $141.1M, WRBY gained 27% with Q3 revenue of $244.7M, and CCLD advanced 20% with Q3 revenue of $33.7M. All companies provided full-year outlooks.

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NASDAQ: CCLD CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA SOMERSET, N.J., November 5, 2026 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 CareCloud Promotes Bonnie Boyer to Chief Financial Officer to Lead the Next Growth Phase Experienced finance executive and CPA promoted as CareCloud scales its profitable, AI-powered healthcare technology platform; Norman Roth transitions from Interim CFO to Advisor

CareCloud (CCLD) reported Q2 2026 revenue of $31.9 million, up 16% year over year, mainly from the Medsphere acquisition. GAAP net income was $1.1 million, with breakeven GAAP EPS. Adjusted EBITDA was $5.9 million. The company redeemed $38.2 million of Series B preferred stock using a $50 million credit facility and reaffirmed FY2026 guidance: revenue $128-$132 million and adjusted EBITDA $29-$31 million.

CareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CareCloud Reports Second Quarter 2026 Results Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income SOMERSET, N.J., August 6, 2026 (GLOBE NEWSWIRE)— CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle mana

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT dated as of June 25, 2026, effective as of May 6, 2026 among CARECLOUD, INC. , a Delaware corporation, as Borrower, and The Lenders Party Hereto and CITIZENS BANK, N.A. , as Administrative Agent, Sole L

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-3.1 2 ex3-1.htm EX-3.1 Exhibit 3.1 CareCloud, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: March 24, 2026 1. General. (a) Eligible Award Recipients. The persons eligible to receive Awards are Employees, Directors and Consultants. (b) Available Awards. The

CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B preferred shares for January, February, and March 2026. The company also declared an additional dividend for Series B to address an arrearage. Series A was mandatorily converted and delisted in March 2025, while Series B continues to trade under CCLDO with a declining redemption price schedule.